$0 Now, Bigger Costs Later

While zero-dollar copays may appear to benefit patients by eliminating out-of-pocket costs, this approach can mask deeper harms. Below is a breakdown of how “free at the point of service” medication models can inadvertently create risks for both patients and the pharmacies that serve them. These consequences, often overlooked, can distort care, erode value, and undermine the long-term sustainability of quality pharmacy services.

Harm to patients:

• Moral Hazard in Medication Use: When medications are “free” at the point of service, patients might be less discerning about whether a prescription is necessary, potentially leading to overreliance or misuse.
• Lack of Consumer Cost Awareness: Zero-dollar copays can obscure the actual cost of medications, preventing patients from making informed healthcare decisions and understanding the true economic impact of their choices.
• Reduced Incentives for Quality Improvement: Without a direct cost to the consumer, pharmacies and healthcare providers might feel less pressure to improve service quality, patient counseling, or even innovate care practices./Diminished Market Competition: When pricing signals are removed from the consumer’s perspective, it can reduce competitive pressure among pharmacies to offer better value or improved services.
• Distortion of Adherence Measurements: Adherence is often measured by prescription fill rates. When medications cost nothing, patients face no barrier to refilling, even if they already have a sufficient supply. This leads to artificially inflated adherence metrics that do not accurately reflect true medication use.
• Diminished Value Perception/Potential worsened adherence: When a service (or medication) costs nothing, patients may not value it as highly — similar to how gyms with higher fees often see higher engagement.

Harm to pharmacies:

• Devaluation of Pharmacy Services: Patients may perceive pharmacy services as less valuable when medications are “free,” undermining the professional expertise of pharmacists.
• Hidden Revenue Losses: The ability to hide profit margins behind a $0 copay can limit visible revenue streams, making it difficult to justify wage increases or reinvest in quality improvements.
• Reduced Negotiation Leverage: The lack of direct patient cost may weaken the pharmacy’s position when negotiating with insurers or other payers, as the true value of the service is not readily apparent.

There is no such thing as a free prescription.

When the price to the patient is zero, the cost doesn’t disappear, it simply shifts. Often, it does so in ways that erode accountability, obscure value, and distort incentives. Patients lose the ability to make informed choices, providers lose the motivation to compete on service and quality, and pharmacies lose the leverage to survive. In any system where the consumer is shielded from cost, inefficiency thrives and value deteriorates. If we want a healthcare model that respects both patients and professionals, we must stop pretending that “free” is the goal. We must demand transparency, efficiency, and real value.

To see what that future looks like today, visit www.costpluspharmacies.com.